Adams Kendra 4
4 · C4 Therapeutics, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-16+2,250→ 84,289 total - Tax Payment
Common Stock
2024-09-16$6.36/sh−661$4,204→ 83,628 total - Exercise/Conversion
Performance Restricted Stock Units
2024-09-16−2,250→ 14,250 totalExp: 2025-02-28→ Common Stock (2,250 underlying)
Footnotes (2)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person.